» Market Update Chordate Medical: “We are in a favorable position”
» Invent Medic enters France
» Scandion's CMO comments on progress in PANTAX
» Vinnova leads the work on a new innovation cluster
» Top five life science stocks of the first quarter
Read BioStock's newsletter for v.14 here.
Morning news
Pharmacologists Partner B. Brown installs DrugLog of San Pedro de Alcantara Hospital in Spain. Read more.
Gabather receives approval from the Japan Patent Office (JPO). Read more.
Lipigon presents at the Young Shareholders' Annual Convention. Read moreThe company has also published an interview with the CEO Stefan K. Nilsson. Read more.
Orthoma has submitted the technical documentation for OTS Spine Plan for MDR audit by notified body. Read more.
Qlife has secured top guarantors in the ongoing rights issue. Read more.
Redeye has published analyses on Newbury Pharmaceuticals (Read more) and on Biovica (Read more).
Targovax has announced its financial calendar. Read more.
Annual Reports:
CellaVision Corline Biomedical Elos Medtech Guard Therapeutics Photocure Q-line SynAct Pharma
Interim reports:
Summons:
Bone support Diagonal Bio Gentian Diagnostics iZafe Group Medclair Mentice Photocure Respirator SynAct Pharma ViroGates
Communiqués:
Change in votes and equity:
News since Wedday lunch
Alzinova's all patients in the phase Ib study with the vaccine candidate ALZ-101 against Alzheimer's disease has received the last dose. Read more.
Cline Scientific has received Notice of Allowance for StemCART in Europe. Read more.
OnDose has received its first patent in the United States. Read more.
Immunovia has announced the outcome of the rights issue. Read more.
SpectraCure has arranged a trial meeting in Milan. Read more.
Medim has updated on the company's activities. Read more.
2cureX has presented preliminary results for Q1 2023. Read moreThe company has also received grants from Denmark's Innovation Fund. Read more.
Aspect Biosystems and Novo Nordisk enters into a partnership to develop bioprinted tissue drugs for diabetes and obesity. Read more.
In study at Monivents Neo Training has been published in the journal Pediatrics. Read more.
Scandinavian ChemoTech invites you to a live interview with the CEO Mohan Frick. Read more.
Q-line has updated the time for presentation at the Life Science Investor Conference in Copenhagen. Read more.
Zealand Pharma attending Needham Virtual Healthcare Conference. Read more.
This morning's price development
Winner: Lipigon 22,7%, Redwood Pharma 20,0%, Qliro 20,0%, Pila Pharma 14,3%, Ortivus 11,8%
Förlorare: Raytelligence – 24,5%, BiBBInstruments -10,8%, Abera Bioscience -10,2%, Duearity -6,4%, RLS Global -6,4%
Index: OMXS30 2 215%, Healthcare 0,04%